A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109

This study is currently recruiting participants.
Verified June 2012 by Green Cross Corporation
Sponsor:
Collaborator:
Korean Center for Disease Control and Prevention
Information provided by (Responsible Party):
Green Cross Corporation
ClinicalTrials.gov Identifier:
NCT01624532
First received: March 6, 2012
Last updated: June 19, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2013
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)